SCHEMBL8375140

SCHEMBL8375140

CCCNc1ccncc1OC(=O)N(CC)CC

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM6B O15054 2/20 0.51
KDM4C Q9H3R0 2/20 0.51
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.41
LMNA P02545 4/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
ECE1 P42892 1/20 0.38
MUS81 Q96NY9 1/20 0.38
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37
LATS1 O95835 1/20 0.37
P2RX4 Q99571 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8376699 0.89 MEN1 (0.46) KDM6BKDM4CMEN1KMT2AHSD17B10
SCHEMBL8374736 0.84 KDM6B (0.51) KDM6BKDM4CMEN1KMT2AHSD17B10
SCHEMBL8376712 0.82 HSD17B10 (0.66) MEN1KMT2AHSD17B10KDM4ELMNA
SCHEMBL8376732 0.82 KDM4C (0.52) KDM6BKDM4CHSD17B10KDM4ELMNA
SCHEMBL8375863 0.79 MEN1 (0.47) MEN1KMT2AHSD17B10KDM4ELMNA
SCHEMBL7364409 0.79 MEN1 (0.50) MEN1KMT2AHSD17B10KDM4ELMNA
SCHEMBL8375135 0.77 MEN1 (0.49) MEN1KMT2AHSD17B10KDM4ELMNA
SCHEMBL7368604 0.77 LMNA (0.54) MEN1KMT2AHSD17B10KDM4ELMNA
SCHEMBL8375136 0.77 HSD17B10 (0.46) MEN1KMT2AHSD17B10KDM4ELMNA
SCHEMBL29956916 0.76 LMNA (0.49) MEN1KMT2AHSD17B10KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US claimed
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US disclosed
EP-0477903-A2 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-04-01 EP disclosed